TrialThe Journal of dermatology2019

Adjuvant therapy with nivolumab versus ipilimumab after complete resection of stage III/IV melanoma: Japanese subgroup analysis from the phase 3 CheckMate 238 study.

Kenji Yokota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.